雷蒙德詹姆斯公司:维持ARS Pharmaceuticals评级

证券之星
15 Jan

雷蒙德詹姆斯公司:维持ars pharmaceuticals(SPRY.US)评级,由强烈买入调整至强烈买入评级,目标价由26.00美元调整至28.00美元。ARS Pharmaceuticals(SPRY.US)公司简介:ARS Pharmaceuticals Inc是一家生物制药公司,专注于开发用于紧急治疗I型过敏反应(包括过敏反应)的新型、潜在全新候选产品neffy。neffy是一种专有的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10